NR1I2 and colorectal carcinoma: The response of HCT116, DLD-1, and SW480 CRC cell lines was measured after treatment with 10 μΜ of Irinotecan and/or siRNA against PXR for 48 h (Figure 2A) by using the MTT-viability assay.